XBIT Xbiotech Inc.
Fundamentals / CIK 0001626878 / USDXbiotech Inc. reported $128.6M in total assets and a net loss of $43.59M through December 31, 2025 from SEC EDGAR filings.
Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open XBIT in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.
-
Revenue FY 2025-- Dec 31, 2025
-
Operating Income FY 2025-$47.49M Operating profit
-
Net Income FY 2025-$43.59M GAAP bottom line
-
Diluted EPS FY 2025-$1.49 Split-adjusted
-
Free Cash Flow FY 2025-$41.00M Operating CF less CapEx
-
Cash & ST Investments Sep 30, 2026$105.0M Total debt: --
Annual revenue and net income
10 fiscal years (2016 to 2025), reported in USD.
Financial statements and ratios
Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.
Income Statement (Annual) · Reported in USD · Newest filing period first.
| Income Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | -- | -- | $0 | $4.01M | $18.39M | $44.00M | $0 | $0 | -- | -- |
| Cost of Revenue | -- | -- | $0 | $651K | $5.82M | $34.55M | $0 | $0 | -- | -- |
| Gross Profit | -- | -- | $0 | $3.36M | $12.57M | $9.45M | $0 | $0 | -- | -- |
| Research & Development | $47.39M | $37.76M | $32.85M | $31.54M | $28.27M | $9.53M | $24.09M | $15.72M | $26.42M | $42.49M |
| Total Operating Expenses | -- | $42.47M | $37.51M | $37.85M | $37.66M | $27.73M | $31.23M | $20.99M | $34.06M | $52.76M |
| Operating Income | -$55.69M | -$42.47M | -$37.51M | -$34.49M | -$25.08M | -$18.28M | -$31.23M | -$20.99M | -$34.06M | -$52.76M |
| EBITDA | -$54.00M | -$40.73M | -$35.81M | -$31.88M | -$22.43M | -$16.04M | -$28.87M | -$18.56M | -$32.58M | -$52.06M |
| Income Before Tax | -$45.30M | -$38.56M | -$24.31M | -$33.59M | -$25.46M | -$12.83M | $718.5M | -$21.14M | -$33.15M | -$52.76M |
| Income Tax Expense | $235K | -$32K | $244K | -$688K | -$8.04M | -$1.61M | $49.82M | $0 | $0 | $0 |
| Net Income | -$45.54M | -$38.53M | -$24.56M | -$32.90M | -$17.41M | -$11.22M | $668.6M | -$21.14M | -$33.15M | -$52.76M |
| Basic EPS | -$1.49 | -$1.26 | -$0.81 | -$1.08 | -$0.58 | -$0.36 | $17.17 | -$0.59 | -$0.95 | -$1.63 |
| Diluted EPS | -$1.49 | -$1.26 | -$0.81 | -$1.08 | -$0.58 | -$0.36 | $14.44 | -$0.59 | -$0.95 | -$1.63 |
| Basic Shares Outstanding | 30.5M | 30.5M | 30.4M | 30.4M | 30.0M | 30.8M | 38.9M | 35.8M | 34.9M | 32.4M |
| Diluted Shares Outstanding | 30.5M | 30.5M | 30.4M | 30.4M | 30.0M | 30.8M | 46.3M | 35.8M | 34.9M | 32.4M |
Income Statement (Quarterly) · Reported in USD · Newest filing period first.
| Income Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Research & Development | $4.66M | $5.30M | $5.21M | $25.36M | $5.08M | $5.34M | $11.62M | $7.82M |
| Total Operating Expenses | $5.32M | $6.15M | -- | -- | $6.05M | $6.34M | $13.55M | $8.75M |
| Operating Income | -$5.32M | -$6.15M | -$6.27M | -$29.75M | -$6.05M | -$6.34M | -$13.55M | -$8.75M |
| EBITDA | -$5.07M | -$5.84M | -$5.94M | -$29.38M | -$5.62M | -$5.90M | -$13.11M | -$8.31M |
| Income Before Tax | -$4.42M | -$6.68M | -$5.46M | -$26.82M | -$5.91M | -$1.73M | -$10.86M | -$10.55M |
| Income Tax Expense | $35K | $46K | $49K | $76K | $102K | $28K | $29K | -$41K |
| Net Income | -$4.46M | -$6.73M | -$5.50M | -$26.89M | -$6.01M | -$1.76M | -$10.88M | -$10.51M |
| Basic EPS | -$0.15 | -$0.22 | -$0.18 | -- | -$0.20 | -$0.06 | -$0.36 | -- |
| Basic Shares Outstanding | 30.5M | 30.5M | 30.5M | -- | 30.5M | 30.5M | 30.5M | -- |
Balance Sheet (Annual) · Reported in USD · Newest filing period first.
| Balance Sheet | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $125.6M | $172.7M | $200.0M | $157.3M | $237.0M | $237.4M | $714.6M | $15.82M | $31.77M | $34.32M |
| Short-Term Investments | -- | -- | $0 | $60.17M | $0 | -- | -- | -- | -- | -- |
| Cash & Short-Term Investments | $125.6M | $172.7M | $200.0M | $217.5M | $237.0M | $237.4M | $714.6M | $15.82M | $31.77M | $34.32M |
| Accounts Receivable, Net | -- | $700K | $860K | $1.22M | $0 | $4.11M | $0 | -- | -- | -- |
| Total Current Assets | $127.0M | $174.6M | $201.7M | $219.8M | $246.9M | $325.9M | $716.3M | $17.02M | $33.33M | $36.93M |
| Property, Plant & Equipment, Net | $23.13M | $24.53M | $24.90M | $26.26M | $28.31M | $27.34M | $25.17M | $27.33M | $29.64M | $10.14M |
| Total Non-Current Assets | $23.13M | $24.53M | $24.90M | $26.26M | $28.31M | $27.87M | $100.6M | $27.33M | $29.64M | $30.12M |
| Total Assets | $150.1M | $199.1M | $226.6M | $246.1M | $275.2M | $353.7M | $816.9M | $44.34M | $62.97M | $67.05M |
| Accounts Payable | $1.53M | $2.22M | $2.52M | $2.41M | $2.07M | $2.49M | $2.15M | $1.65M | $1.73M | $4.43M |
| Deferred Revenue (Current) | -- | -- | -- | -- | -- | $0 | $4.50M | -- | -- | -- |
| Total Current Liabilities | $7.93M | $15.11M | $6.10M | $4.07M | $3.45M | $3.98M | $60.19M | $2.94M | $2.79M | $7.96M |
| Total Non-Current Liabilities | $1.80M | $1.72M | $1.67M | $1.64M | $2.34M | $1.12M | $1.06M | $3.0K | $18K | $23K |
| Total Liabilities | $9.73M | $16.82M | $7.77M | $5.70M | $5.79M | $5.11M | $61.25M | $2.95M | $2.81M | $7.99M |
| Common Stock | $276.7M | $273.1M | $271.2M | $267.3M | $262.3M | $249.8M | $324.8M | $279.4M | $277.5M | $242.4M |
| Retained Earnings | -$136.4M | -$90.84M | -$52.31M | -$27.75M | $5.15M | $97.57M | $430.9M | -$237.7M | -$216.6M | -$183.4M |
| Accumulated Other Comp. Income | -- | -- | $0 | $826K | $1.97M | $1.27M | -$106K | -$255K | -$768K | $57K |
| Total Stockholders' Equity | $140.3M | $182.3M | $218.8M | $240.4M | $269.4M | $348.6M | $755.6M | $41.40M | $60.16M | $59.06M |
| Total Equity | $140.3M | $182.3M | $218.8M | $240.4M | $269.4M | $348.6M | $755.6M | $41.40M | $60.16M | $59.06M |
Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.
| Balance Sheet | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $105.0M | $109.5M | $115.5M | $125.6M | $147.4M | $152.9M | $155.9M | $172.7M |
| Cash & Short-Term Investments | $105.0M | $109.5M | $115.5M | $125.6M | $147.4M | $152.9M | $155.9M | $172.7M |
| Accounts Receivable, Net | -- | -- | -- | -- | $450K | $480K | $480K | $700K |
| Total Current Assets | $106.4M | $111.2M | $117.0M | $127.0M | $149.0M | $154.9M | $157.7M | $174.6M |
| Property, Plant & Equipment, Net | $22.25M | $22.49M | $22.79M | $23.13M | $23.47M | $23.79M | $24.18M | $24.53M |
| Total Non-Current Assets | $22.25M | $22.49M | $22.79M | $23.13M | $23.47M | $23.79M | $24.18M | $24.53M |
| Total Assets | $128.6M | $133.7M | $139.8M | $150.1M | $172.4M | $178.7M | $181.9M | $199.1M |
| Accounts Payable | $581K | $1.10M | $857K | $1.53M | $1.04M | $1.43M | $1.10M | $2.22M |
| Total Current Liabilities | $2.69M | $3.35M | $3.00M | $7.93M | $3.56M | $3.86M | $5.41M | $15.11M |
| Total Non-Current Liabilities | $1.85M | $1.84M | $1.82M | $1.80M | $1.78M | $1.76M | $1.74M | $1.72M |
| Total Liabilities | $4.55M | $5.19M | $4.82M | $9.73M | $5.34M | $5.62M | $7.15M | $16.82M |
| Common Stock | $277.1M | $277.1M | $276.9M | $276.7M | $276.6M | $276.5M | $276.4M | $273.1M |
| Retained Earnings | -$153.1M | -$148.6M | -$141.9M | -$136.4M | -$109.5M | -$103.5M | -$101.7M | -$90.84M |
| Total Stockholders' Equity | $124.1M | $128.5M | $135.0M | $140.3M | $167.1M | $173.1M | $174.7M | $182.3M |
| Total Equity | $124.1M | $128.5M | $135.0M | $140.3M | $167.1M | $173.1M | $174.7M | $182.3M |
Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.
| Cash Flow Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -$45.54M | -$38.53M | -$24.56M | -$32.90M | -$17.41M | -$11.22M | $668.6M | -$21.14M | -$33.15M | -$52.76M |
| Depreciation & Amortization | $1.69M | $1.75M | $1.70M | $2.61M | $2.65M | $2.24M | $2.36M | $2.43M | $1.48M | $698K |
| Stock-Based Compensation | $3.62M | $1.75M | $3.26M | $5.06M | $4.46M | $12.58M | $3.36M | $1.66M | $1.75M | $5.57M |
| Change in Receivables | -- | -- | -- | $0 | $4.11M | -$4.11M | $0 | $0 | -- | -- |
| Change in Payables | -$688K | -$364K | $91K | $357K | -$514K | -$334K | $496K | -$78K | -$2.70M | -$981K |
| Operating Cash Flow | -$39.92M | -$30.96M | -$18.73M | -$14.82M | $69.44M | -$65.15M | -$18.27M | -$16.54M | -$33.65M | -$46.02M |
| Capital Expenditure | -$289K | -$1.30M | -$362K | -$585K | -$3.52M | -$3.73M | -$204K | -$122K | -$1.41M | -$4.75M |
| Free Cash Flow | -$40.21M | -$32.27M | -$19.09M | -$15.41M | $65.92M | -$68.88M | -$18.47M | -$16.66M | -$35.05M | -$50.76M |
| Investing Cash Flow | -$289K | -$1.30M | $61.50M | -$63.89M | -$3.52M | -$3.73M | $674.8M | -$122K | -$1.41M | -$13.91M |
| Common Stock Issued | -- | -- | $4.8K | -- | $8.00M | $10.30M | $3.80M | -- | $703K | $1.81M |
| Share Repurchases | -- | $0 | -$14K | $0 | -- | -- | -- | -- | -- | -- |
| Dividends Paid | -- | -- | -- | $0 | -$75.00M | $0 | $0 | -- | -- | -- |
| Financing Cash Flow | -$10.25M | $10.45M | -$9.0K | $0 | -$67.01M | -$409.7M | $42.10M | $201K | $33.32M | $2.94M |
| Net Change in Cash | -$47.13M | -$27.35M | $42.72M | -$79.68M | -$383K | -$477.2M | $698.8M | -$15.95M | -$2.56M | -$56.73M |
Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.
| Cash Flow Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Net Income | -$4.46M | -$6.73M | -$5.50M | -$26.89M | -$6.01M | -$1.76M | -$10.88M | -$10.51M |
| Depreciation & Amortization | $252K | $302K | $332K | $378K | $427K | $439K | $442K | $439K |
| Stock-Based Compensation | $64K | $172K | $172K | $162K | $24K | $107K | $3.33M | $628K |
| Change in Payables | -$522K | $246K | -$678K | $492K | -$385K | $330K | -$1.12M | $653K |
| Operating Cash Flow | -$4.52M | -$4.51M | -$8.97M | -$22.95M | -$4.26M | -$5.99M | -$6.72M | -$6.54M |
| Capital Expenditure | -$12K | $0 | $0 | -$34K | -$110K | -$51K | -$94K | -$84K |
| Free Cash Flow | -$4.53M | -$4.51M | -$8.97M | -$22.99M | -$4.37M | -$6.04M | -$6.81M | -$6.62M |
| Investing Cash Flow | -$17K | -$4.0K | $9.0K | -$34K | -$110K | -$51K | -$94K | -$84K |
| Financing Cash Flow | $0 | $0 | $0 | $0 | $0 | $0 | -$10.25M | $283K |
| Net Change in Cash | -$4.49M | -$5.93M | -$10.09M | -$21.82M | -$5.57M | -$2.96M | -$16.78M | -$10.44M |
Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.
| Ratios & Growth | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | -- | -- | -- | 83.8% | 68.4% | 21.5% | -- | -- | -- | -- |
| Operating Margin | -- | -- | -- | -860.1% | -136.4% | -41.5% | -- | -- | -- | -- |
| Net Profit Margin | -- | -- | -- | -820.4% | -94.7% | -25.5% | -- | -- | -- | -- |
| Return on Equity (ROE) | -32.4% | -21.1% | -11.2% | -13.7% | -6.5% | -3.2% | 88.5% | -51.1% | -55.1% | -89.3% |
| Return on Assets (ROA) | -30.3% | -19.4% | -10.8% | -13.4% | -6.3% | -3.2% | 81.9% | -47.7% | -52.6% | -78.7% |
| Current Ratio | 16.01x | 11.56x | 33.07x | 54.07x | 71.49x | 81.80x | 11.90x | 5.78x | 11.94x | 4.64x |
| Quick Ratio | 15.83x | 11.48x | 32.93x | 53.79x | 68.63x | 60.61x | 11.87x | 5.37x | 11.38x | 4.31x |
| Revenue Growth (YoY) | -- | -- | -100.0% | -78.2% | -58.2% | -- | -- | -- | -- | -- |
| Gross Profit Growth (YoY) | -- | -- | -100.0% | -73.3% | +33.1% | -- | -- | -- | -- | -- |
| Net Income Growth (YoY) | -- | -- | -- | -- | -- | -101.7% | -- | -- | -- | -- |
| EPS Growth (YoY) | -- | -- | -- | -- | -- | -102.1% | -- | -- | -- | -- |
| Operating Cash Flow Growth (YoY) | -- | -- | -- | -121.3% | -- | -- | -- | -- | -- | -- |
| Free Cash Flow Growth (YoY) | -- | -- | -- | -123.4% | -- | -- | -- | -- | -- | -- |
| 5Y Net Income / Share Growth | -- | -107.4% | -- | -- | -- | -- | -- | -- | -- | -- |
Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.
| Ratios & Growth | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | -35.1% | -35.1% | -29.7% | -32.4% | -17.5% | -16.3% | -22.6% | -21.1% |
| Return on Assets (ROA) | -33.9% | -33.8% | -28.7% | -30.3% | -16.9% | -15.8% | -21.7% | -19.4% |
| Current Ratio | 39.51x | 33.15x | 39.03x | 16.01x | 41.78x | 40.16x | 29.15x | 11.56x |
| Quick Ratio | 39.02x | 32.67x | 38.50x | 15.83x | 41.46x | 39.78x | 28.91x | 11.48x |